Skip to main content

Animations

MJFF Publications

2331 - 2340 of 8571 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2022
  • 2021
  • 2020
  • 2022
  • 2022
  • 2020
  • 2020
  • 2021
  • Summary Details
    RESTRICTED
    Title: Diagnosis and Treatment of Parkinson Disease
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2019.22360
    Best OA location URL:
    Citation Count: 1523
  • Summary Details
    RESTRICTED
    Title: Promising drug targets and associated therapeutic interventions in Parkinson’s disease
    Journal Name: Neural Regeneration Research
    Publisher: Medknow
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.4103/1673-5374.306066
    Citation Count: 75
  • Summary Details
    RESTRICTED
    Title: An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration
    Journal Name: Neural Regeneration Research
    Publisher: Medknow
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.4103/1673-5374.338992
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.648532
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/science.abb8587
    Citation Count: 229
  • Summary Details
    RESTRICTED
    Title: Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications
    Journal Name: Pharmacological Reviews
    Publisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1124/pharmrev.122.000654
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Management of psychiatric and cognitive complications in Parkinson’s disease
    Journal Name: BMJ
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/bmj-2021-068718
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
    Journal Name: Gut
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/gutjnl-2020-322429
    Citation Count: 93
  • Summary Details
    RESTRICTED
    Title: Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action
    Journal Name: European Neuropsychopharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.euroneuro.2020.05.006
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Fidelity of the PINK1 knockout rat to oxidative stress and other characteristics of Parkinson disease
    Journal Name: Free Radical Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2020.12.004
    Best OA location URL:
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.